Irregular Rhythm Notification Feature (IRNF)

Apple Inc. · K231173 · 2023-07-21

Irregular Rhythm Notification Feature (IRNF) is an AI-enabled medical device from Apple Inc., listed by FDA (510(k), K231173) with a decision date of 2023-07-21. Review panel: Cardiovascular.

FDA submission numberK231173
Pathway510(k)
CompanyApple Inc.
Review panel (specialty)Cardiovascular
FDA decision date2023-07-21
DecisionSubstantially Equivalent
Product codeQDB
ClassificationPhotoplethysmograph Analysis Software For Over-The-Counter Use
Device class2
Regulation number870.2790
Review time (calendar days)87
Applicant countryUS

Official FDA database record · FDA AI-enabled device list

More devices from Apple Inc. · All Cardiovascular AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.